Enterprise record
Alpha ID: alpha:company:895cb27d-9ee1-4d8e-acc5-ff72b64794d1Version: public-1As of: unavailable
12 published Claims2 sources
Key Claims
Board and committees
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Sep 30, 2026
Supports 4 claims
- Legal Name: Ascendis Pharma A/S · Claim reviewed: Sep 30, 2026
- Entity Status: Public listing published · Claim reviewed: Sep 30, 2026
- Published Fact: US · Claim reviewed: Sep 30, 2026
- Published Fact: Healthcare · Claim reviewed: Sep 30, 2026
Ascendis Pharma A/S key executives
other · Source published: Apr 22, 2026 · Retrieved: Apr 22, 2026
Supports 8 claims
- Leadership Role: Chad Fugure: Vice President of Investor Relations · Claim reviewed: Sep 30, 2026
- Leadership Role: Flemming Steen Jensen: Executive Vice President of Product Supply & Quality · Claim reviewed: Sep 30, 2026
- Leadership Role: Jan Moller Mikkelsen: President, Chief Executive Officer, Member of Executive Board & Executive Director · Claim reviewed: Sep 30, 2026
- Leadership Role: Mads Bodenhoff: Senior VP, Head of Finance & Principal Accounting Officer · Claim reviewed: Sep 30, 2026
- Leadership Role: Michael Wolff Jensen: Executive VP, Chief Legal Officer & Member of the Executive Board · Claim reviewed: Sep 30, 2026
- Leadership Role: Pedersen Anni Lotte Kirstine Sonderbjerg: Executive Vice President, Chief Administrative Officer & Member of the Executive Board · Claim reviewed: Sep 30, 2026
- Leadership Role: Scott T. Smith: Chief Financial Officer, Executive Vice President & Member of Executive Board · Claim reviewed: Sep 30, 2026
- Leadership Role: Sherrie Glass: Chief Business Officer · Claim reviewed: Sep 30, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-30
- Board and committees
- published
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed

